Applying Guideline-Directed Care For Patients With T2D: Focus on Glucagon-Like Peptide-1 Receptor Agonists
Image For Activity Cover
Availability
On-Demand
Expires on Nov 05, 2027
Cost
$0.00
Credit Offered
1.5 AOA Category 1-A Credits
Converted Document

[Insert Logo]

Applying Guideline-Directed Care for Patients With T2D: Focus on Glucagon-Like Peptide-1 Receptor Agonists

Speakers:  Kathleen Dungan, MD, MPH; Jay Schubrook, DO, FACOFP

OBJECTIVES:

Explain how glucagon-like peptide-1 receptor agonists (GLP-1 RAs) function in treating type 2 diabetes (T2D) and their extra-glycemic effects

Examine safety considerations related to GLP-1 RAs and explore effective approaches for addressing adverse events associated with their use

Evaluate the guidance for comprehensive approaches to care and early management of T2D

Expiration Date: November 5, 2027

The AOA designates this activity for a maximum of 1.5 AOA Category 1-A Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

This educational activity is supported by an independent educational grant from Novo Nordisk, Inc.

Powered By